Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Serp-1 in Acute Coronary Syndromes
NCT00243308Phase 2Terminated
- Sponsor
- Viron Therapeutics
- Start
- Oct 2005
- Primary completion
- Jul 2008
- Modality
- Replacement Enzymes, Fc-Fusion Proteins
- Countries
- 2
01
Overview
A Phase 2 trial of serp-1 in acute coronary syndrome (ACS), sponsored by Viron Therapeutics. Started Oct 2005; status: terminated.
02
Drugs
serp-1
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on NCT00243308.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00243308.